|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-2-25
|
|
pubmed:abstractText |
Recombinant human erythropoietin (r-HuEPO) is widely used to correct renal anemia in uremic patients. Interestingly, some chronic hemodialysis (HD) patients can maintain high hemoglobin level without the need of r-HuEPO. The aim of this study is to investigate clinical features, iron metabolism and erythropoiesis of these r-HuEPO-independent HD patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0301-0430
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
92-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15730050-Adult,
pubmed-meshheading:15730050-Aged,
pubmed-meshheading:15730050-Anemia,
pubmed-meshheading:15730050-Erythropoiesis,
pubmed-meshheading:15730050-Erythropoietin,
pubmed-meshheading:15730050-Female,
pubmed-meshheading:15730050-Hematinics,
pubmed-meshheading:15730050-Hemoglobins,
pubmed-meshheading:15730050-Humans,
pubmed-meshheading:15730050-Iron,
pubmed-meshheading:15730050-Kidney Failure, Chronic,
pubmed-meshheading:15730050-Male,
pubmed-meshheading:15730050-Middle Aged,
pubmed-meshheading:15730050-Recombinant Proteins,
pubmed-meshheading:15730050-Renal Dialysis,
pubmed-meshheading:15730050-Retrospective Studies,
pubmed-meshheading:15730050-Risk Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
|
|
pubmed:affiliation |
Division of Nephrology, Department of Internal Medicine, Chang-Gung Memorial Hospital, Kaohsiung, Taiwan.
|
|
pubmed:publicationType |
Journal Article
|
